Search Tag: Vaccine

2022 11 Jan

Cleveland Clinic researchers along with Anixa Biosciences have initiated a phase 1 clinical trial to test a vaccine intended to prevent triple-negative breast cancers (TNBC). This trial is a first of its kind.   TNBCs are named so because they test negative for estrogen receptors, progesterone receptors, and excess HER2 protein. Since these are...Read more